Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (191-200 of 451) with videos related to

Pageof 46
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2020
Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus InfectionLisette A P Krassenburg, Wayel R Zanjir, Firas Georgie, et al.
Annals of Surgical Oncology|December 14, 2022
Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting AntiviralsLuckshi Rajendran, Woo Jin Choi, Hala Muaddi, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countriesFeng Tian, Farinaz Forouzannia, Zeny Feng, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2015
Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomesA C Cheung, L Lapointe-Shaw, M Kowgier, et al.
Paediatrics & Child Health|September 8, 2025
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of ageMia J Biondi, Jennifer Flemming, Jennifer van Gennip, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluationMuhammad Atif Zahoor, Nahla FadlElMawla, Adrian Kuipery, et al.
JAMA|November 12, 2014
Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general populationAdriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.
The American Journal of Gastroenterology|March 15, 2017
Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed CryoglobulinemiaJoel S Emery, Magdalena Kuczynski, Danie La, et al.
Breast Cancer Research and Treatment|May 13, 2015
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysisWilliam W L Wong, Lisa K Hicks, Hong-Anh Tu, et al.
Canadian Liver Journal|March 13, 2023
Lessons from First Nations partnerships in hepatitis C research and the co-creation of knowledgeAndrew B Mendlowitz, Karen E Bremner, Jordan J Feld, et al.
Pageof 46

Showing results (191-200 of 451) with videos related to

Sort By:
Pageof 46
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2020
Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus InfectionLisette A P Krassenburg, Wayel R Zanjir, Firas Georgie, et al.
Annals of Surgical Oncology|December 14, 2022
Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting AntiviralsLuckshi Rajendran, Woo Jin Choi, Hala Muaddi, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countriesFeng Tian, Farinaz Forouzannia, Zeny Feng, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2015
Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomesA C Cheung, L Lapointe-Shaw, M Kowgier, et al.
Paediatrics & Child Health|September 8, 2025
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of ageMia J Biondi, Jennifer Flemming, Jennifer van Gennip, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluationMuhammad Atif Zahoor, Nahla FadlElMawla, Adrian Kuipery, et al.
JAMA|November 12, 2014
Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general populationAdriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.
The American Journal of Gastroenterology|March 15, 2017
Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed CryoglobulinemiaJoel S Emery, Magdalena Kuczynski, Danie La, et al.
Breast Cancer Research and Treatment|May 13, 2015
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysisWilliam W L Wong, Lisa K Hicks, Hong-Anh Tu, et al.
Canadian Liver Journal|March 13, 2023
Lessons from First Nations partnerships in hepatitis C research and the co-creation of knowledgeAndrew B Mendlowitz, Karen E Bremner, Jordan J Feld, et al.
Pageof 46